Abstract Objectives/Hypothesis: Is the severity of acute oral mucositis in patients who receive
postoperative intensity‐modulated radiotherapy (PO‐IMRT) for oral tongue squamous cell …

PURPOSE: To define the roles of radiotherapy and chemotherapy on the risk of Grade 3+
mucositis during intensity-modulated radiation therapy (IMRT) for oropharyngeal cancer …

Oral mucositis is a common dose-limiting toxicity during radiotherapy with or without
chemotherapy in head and neck cancer patients. This potentially severe complication …

Purpose: To study the risk, outcomes, and costs of radiation-induced oral mucositis (OM)
among patients receiving radiotherapy (RT) to head and neck primary cancers. Methods and …

The aim of this study was to assess the treatment results and toxicity profiles of post-
operative conventional radiotherapy (Conv-RT) and intensity-modulated radiotherapy …

Background We compared outcomes and xerostomia grade after postoperative intensity‐
modulated radiation therapy (IMRT) and conventional radiotherapy (RT) in patients with oral …

Objectives The objective of this network meta-analysis is to optimize the prophylactic
treatment for radiotherapy-induced oral mucositis in patients with head and neck cancer …

OBJECTIVES: To review outcomes and analyze the patterns of locoregional recurrence of
oral cavity squamous cell carcinoma (OCSCC) treated with surgery and postoperative …

Purpose/Objective: Acute mucositis is a common acute toxicity for patients treated with
radiation therapy for head and neck cancer (HNC) and is significantly increased when …

Background The purpose of this study was to assess predictors of mucositis in
oropharyngeal and oral cavity cancer after definitive or adjuvant volumetric modulated arc …